- Home
- THFF vs PLRX Comparison
THFF vs PLRX Comparison
Compare THFF & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- PLRX
- Stock Information
- Founded
- THFF 1984
- PLRX 2015
- Country
- THFF United States
- PLRX United States
- Employees
- THFF N/A
- PLRX N/A
- Industry
- THFF Major Banks
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- PLRX Health Care
- Exchange
- THFF Nasdaq
- PLRX Nasdaq
- Market Cap
- THFF 599.3M
- PLRX 641.5M
- IPO Year
- THFF N/A
- PLRX 2020
- Fundamental
- Price
- THFF $44.09
- PLRX $11.77
- Analyst Decision
- THFF Hold
- PLRX Strong Buy
- Analyst Count
- THFF 1
- PLRX 7
- Target Price
- THFF $45.00
- PLRX $40.50
- AVG Volume (30 Days)
- THFF 46.9K
- PLRX 544.4K
- Earning Date
- THFF 01-28-2025
- PLRX 02-26-2025
- Dividend Yield
- THFF 4.66%
- PLRX N/A
- EPS Growth
- THFF N/A
- PLRX N/A
- EPS
- THFF 3.68
- PLRX N/A
- Revenue
- THFF $190,119,000.00
- PLRX N/A
- Revenue This Year
- THFF N/A
- PLRX N/A
- Revenue Next Year
- THFF $12.01
- PLRX N/A
- P/E Ratio
- THFF $11.97
- PLRX N/A
- Revenue Growth
- THFF N/A
- PLRX N/A
- 52 Week Low
- THFF $34.58
- PLRX $10.22
- 52 Week High
- THFF $51.87
- PLRX $18.92
- Technical
- Relative Strength Index (RSI)
- THFF 33.20
- PLRX 34.86
- Support Level
- THFF $42.65
- PLRX $12.40
- Resistance Level
- THFF $45.87
- PLRX $13.71
- Average True Range (ATR)
- THFF 1.08
- PLRX 0.76
- MACD
- THFF -0.33
- PLRX -0.17
- Stochastic Oscillator
- THFF 29.57
- PLRX 18.66
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services, and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.